ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 382

Nailfold Capillary Changes in the Adult Newly Onset-Dermatomyositis: A Prospective Cohort Study

Renata Miossi1, Fernando Henrique Carlos de Souza2 and Samuel K Shinjo3, 1Rheumatology, Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil, 2Rheumatology Division, Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil, 3Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Angiogenesis, Dermatomyositis and nailfold capillaroscopy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Muscle Biology, Myositis and Myopathies Poster I: Clinical Features and Disease Course

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: There is currently no study in newly onset dermatomyositis (DM) regarding nailfold capillaroscopy (NC) findings, angiogenic cytokines, disease related clinical, laboratory and treatment features. Therefore, the aims of the present study were: (a) to analyze cross-sectionally and prospectively NC findings in newly onset-DM; (b) to correlate NC findings with serum angiogenic cytokines [angiogenin (ANG), vascular endothelial growth factor-1 (VEGF1)] and DM clinical and laboratory features.

Methods: Twenty-three patients with DM with less than 12 months of symptoms were included. All the patients met at least four of the five criteria of Bohan and Peter criteria, including classical cutaneous lesions (heliotrope rash and/or Gottron’s papules) and the new European League Against Rheumatism / American College of Rheumatology (EULAR / ACR) classification criteria for DM. To assess serum cytokine levels, age, gender and ethnicity-matched 23 healthy volunteers were recruited as a control group. NC characteristics and DM activity parameters were analyzed. Additionally, 15 out of 23 patients were also assessed prospectively after a median duration of 3.21 years.

Results: A significantly higher serum ANG and VEGF1 levels (P=0.017 and P<0.001, respectively) were observed in DM patients compared to controls. Capillary density and avascular areas correlated positively (r=0.6; P=0.016) and negatively (r=-0.59; P=0.019) with serum level of ANG. Besides, capillary density correlated inversely with the number of enlarged (r=-0.54; P=0.007); giant capillaries (r=-0.53; P=0.009) and avascular areas (r=-0.84; P<0.001). The number of the enlarged capillaries correlated positively with patient (r=0.49; P=0.016) and physician VAS (r=0.56; P=0.005), presence of facial rash (r=0.44; P=0.035), giant capillaries (r=0.76; P=<0.001) and microhemorrhages (r=0.59; P=0.003). Giant capillaries had positive correlation with physician (r=0.50; P=0.014) and cutaneous VAS (r=0.42; P=0.046), enlarged capillaries (r=0.76; P<0.001), avascular areas (r=0.54; P=0.007), microhemorrhages (r=0.55; P=0.006) and bushy capillaries (r=0.42; P=0.044) and negative with capillary density (r=-0.53; P=0.009). Microhemorrhages correlated positively with “V-neck” sign (r=0.44; P=0.032) and physician VAS (r=0.48; P=0.02). VEGF1 showed no relation to NC parameters neither with DM-related clinical and laboratory features. Longitudinally, all patients had major clinical response with significant improvement in the all NC parameters, except for enlarged and bushy capillaries.

Conclusion: The present data emphasize that NC may be a useful tool to assess disease activity in recently onset-DM and also reinforce the role of ANG in the angiogenesis process in this myopathy.


Disclosure: R. Miossi, None; F. H. C. de Souza, None; S. K. Shinjo, None.

To cite this abstract in AMA style:

Miossi R, de Souza FHC, Shinjo SK. Nailfold Capillary Changes in the Adult Newly Onset-Dermatomyositis: A Prospective Cohort Study [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/nailfold-capillary-changes-in-the-adult-newly-onset-dermatomyositis-a-prospective-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nailfold-capillary-changes-in-the-adult-newly-onset-dermatomyositis-a-prospective-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology